Idiopathic intracranial hypertension, also known as pseudotumor cerebri (PTC), is a very common pathology that causes symptoms such as chronic migraines, vision problems and even depression.
Increased brain pressure is caused by the buildup of blood and cerebrospinal fluid in the brain.
The Israeli startup Vflow, which works on the development of vascular stents with varied applications for cerebral endovascular treatments, presented a device that can expand the veins in the brain, releasing fluid and relieving pressure, and consequently, the associated symptoms.
Anat Horev, co-founder and medical director of the startup, and also head of the Interventional Neuroradiology Unit at Soroka Medical Center in Beersheva, explains that while PTC was recognized 50 years ago, it is only in recent years that it has been treated with the importance it deserves.
Horve explained that millions of patients “with severe migraines and unexplained cases have narrowing of the veins and do not receive adequate treatment.
The Viva Stent device is placed directly into the brain vein where the narrowing occurs, almost immediately improving patients' quality of life.
Due to its flexibility, it guarantees a safer and more effective procedure, minimizing complications that may occur during surgery and improving results for patients.